These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. c-erbB-2 and the "triple-state" in early breast carcinomas. Sivridis E, Stamos C, Fiska A, Nikolettos N, Koukourakis MI, Giatromanolaki A. Med Oncol; 2010 Sep; 27(3):578-84. PubMed ID: 19548127 [Abstract] [Full Text] [Related]
10. Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes. Saghatchian M, Mook S, Pruneri G, Viale G, Glas AM, Guerin S, Cardoso F, Piccart M, Tursz T, Delaloge S, van't Veer L. Breast; 2013 Oct; 22(5):682-90. PubMed ID: 23347730 [Abstract] [Full Text] [Related]
16. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer. Ozmen V, Ozcinar B, Bozdogan A, Eralp Y, Yavuz E, Dincer M. Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653 [Abstract] [Full Text] [Related]
17. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. Angarita FA, Chesney T, Elser C, Mulligan AM, McCready DR, Escallon J. Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372 [Abstract] [Full Text] [Related]
18. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up. Avril A, Le Bouëdec G, Lorimier G, Classe JM, Tunon-de-Lara C, Giard S, MacGrogan G, Debled M, Mathoulin-Pélissier S, Mauriac L, AXIL95 Group. Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421 [Abstract] [Full Text] [Related]